NO933015L - 3-piperidinylmetalkarboksylat-substituerte indoler - Google Patents

3-piperidinylmetalkarboksylat-substituerte indoler

Info

Publication number
NO933015L
NO933015L NO93933015A NO933015A NO933015L NO 933015 L NO933015 L NO 933015L NO 93933015 A NO93933015 A NO 93933015A NO 933015 A NO933015 A NO 933015A NO 933015 L NO933015 L NO 933015L
Authority
NO
Norway
Prior art keywords
alkyl
piperidinyl
metal carboxylate
group
hydrogen
Prior art date
Application number
NO93933015A
Other languages
English (en)
Other versions
NO933015D0 (no
Inventor
Alexander William Oxford
John William Frank Whitehead
John Knight
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO933015D0 publication Critical patent/NO933015D0/no
Publication of NO933015L publication Critical patent/NO933015L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)

Abstract

Indol-derivater med formel (l), hvor R1 representerer et hydrogen- eller halogenatom, hvor R1 representerer et hydrogen- eller halogenatom, eller en Cj.j-alkyl-, ClT6-alkoksy- eller hydroksygruppe; R2 representerer et hydrogenatom eller en C^6- alkyl-, -CH2C2.5-alkenyl- eller -CH2C2_5-alkynylgruppe; R3 representerer et hydrogenatom eller en Cj.j-alkyl- eller C>6- alkoksygruppe; n representerer 2 eller 3; R* representerer en gruppe valgt blant cyano, hydroksyl, C^-alkoksy, fenoksy, C(0)Ci.6-alkyl, C(0)CtHj, -CONR^OR6, -NR5COR', -S02NR5R6 eller -NR5SO2R' (hvor hver av R5 og R6 uavhengig av hverandre repre- senterer et hydrogenatom, en Cj.j-alkyl- eller fenylgruppe) ; og kvat.-ammoniumderivater, piperidin-N-oksyder og farmasoytisk akseptable salter og solvater derav, hvilke forbindelser er serke og spesifikke antagonister mot 5-hydroksytryptamin (5- HT; serotonin).
NO93933015A 1991-02-25 1993-08-24 3-piperidinylmetalkarboksylat-substituerte indoler NO933015L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919103862A GB9103862D0 (en) 1991-02-25 1991-02-25 Chemical compounds
PCT/EP1992/000371 WO1992014727A1 (en) 1991-02-25 1992-02-21 3-piperidinylmethylcarboxylate substituted indoles
APAP/P/1992/000417A AP295A (en) 1991-02-25 1992-08-17 3-Piperidinylmethylcarboxylate substituted indoles.
CN92110050A CN1083059A (zh) 1991-02-25 1992-08-24 3-哌啶甲基羧酸酯取代的吲哚

Publications (2)

Publication Number Publication Date
NO933015D0 NO933015D0 (no) 1993-08-24
NO933015L true NO933015L (no) 1993-08-24

Family

ID=36790873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93933015A NO933015L (no) 1991-02-25 1993-08-24 3-piperidinylmetalkarboksylat-substituerte indoler

Country Status (18)

Country Link
EP (1) EP0501322B1 (no)
JP (1) JPH06505238A (no)
CN (1) CN1083059A (no)
AP (1) AP295A (no)
AT (1) ATE142205T1 (no)
AU (1) AU645402B2 (no)
CA (1) CA2105179A1 (no)
DE (1) DE69213276T2 (no)
ES (1) ES2091963T3 (no)
FI (1) FI933697L (no)
GB (1) GB9103862D0 (no)
HU (1) HUT65486A (no)
IE (1) IE920567A1 (no)
IL (1) IL101042A (no)
MX (1) MX9200762A (no)
NO (1) NO933015L (no)
NZ (1) NZ241704A (no)
WO (1) WO1992014727A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121984T3 (es) * 1991-12-21 1998-12-16 Smithkline Beecham Plc Uso de antagonistas de 5-ht4 para la fabricacion de un medicamento para el tratamiento de la incontinencia urinaria.
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
UA41311C2 (uk) * 1992-03-12 2001-09-17 Смітклайн Бічем Плс КОНДЕНСОВАНІ ІНДОЛЬНІ ПОХІДНІ ЯК АНТАГОНІСТИ 5НТ<sub>4</sub> РЕЦЕПТОРА, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
WO1993024117A2 (en) * 1992-05-23 1993-12-09 Smithkline Beecham Plc Medicaments for the treatment of anxiety
WO1994000113A2 (en) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
GB9221468D0 (en) * 1992-10-13 1992-11-25 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
US5726187A (en) * 1992-10-16 1998-03-10 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
KR950704328A (ko) * 1992-11-05 1995-11-17 데이비드 로버츠 5-HT₄ 수용체 길항제로서의 피페리딘 유도체(Piperidine Derivatives as 5-HT₄ Receptor Antagonists)
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) * 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
GB9725933D0 (en) * 1997-12-05 1998-02-04 Smithkline Beecham Plc Pharmaceuticals
KR20030027010A (ko) * 2000-08-07 2003-04-03 라보라뜨와르 글락소스미스클라인 심방 세동 예방 또는 치료용 의약의 제조에서의 5ｈｔ4수용체 길항제의 용도
IL158445A0 (en) * 2001-04-20 2004-05-12 Wyeth Corp Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
AU2002309585B2 (en) * 2001-04-20 2008-01-31 Wyeth Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
WO2010065743A2 (en) * 2008-12-03 2010-06-10 Nanotherapeutics, Inc. Bicyclic compounds and methods of making and using same
WO2023115449A1 (zh) * 2021-12-23 2023-06-29 宁德时代新能源科技股份有限公司 A/m/x晶体材料、光伏器件及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123485A (ja) * 1983-12-08 1985-07-02 Yoshitomi Pharmaceut Ind Ltd インド−ル−３−カルボキサミド誘導体
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
CA2105179A1 (en) 1992-08-26
IE920567A1 (en) 1992-08-26
HUT65486A (en) 1994-06-28
HU9302414D0 (en) 1993-11-29
EP0501322B1 (en) 1996-09-04
WO1992014727A1 (en) 1992-09-03
AP9200417A0 (en) 1992-10-31
ES2091963T3 (es) 1996-11-16
AP295A (en) 1993-12-29
IL101042A (en) 1996-06-18
NO933015D0 (no) 1993-08-24
AU1209492A (en) 1992-09-15
DE69213276D1 (de) 1996-10-10
FI933697A7 (fi) 1993-08-23
EP0501322A1 (en) 1992-09-02
NZ241704A (en) 1993-11-25
DE69213276T2 (de) 1997-01-23
FI933697A0 (fi) 1993-08-23
GB9103862D0 (en) 1991-04-10
ATE142205T1 (de) 1996-09-15
AU645402B2 (en) 1994-01-13
JPH06505238A (ja) 1994-06-16
MX9200762A (es) 1992-08-01
CN1083059A (zh) 1994-03-02
FI933697L (fi) 1993-08-23
IL101042A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
NO933015L (no) 3-piperidinylmetalkarboksylat-substituerte indoler
NO844565L (no) Fremgangsmaate ved fremstilling av 1h-imidazo(4,5-c)-kinoliner og 1h-imidazo(4,5-c)-kinolin-4-aminer
ZA200206587B (en) Pyrrolopyrimidinone derivatives, process of preparation and use.
KR920008024A (ko) 퀴놀린 유도체
NO955326L (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
FI863020A0 (fi) Foerfarande foer framstaellning av heterocykliska foereningar.
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
ES551987A0 (es) Procedimiento para preparar derivados de cefalosporina.
EP0106281A3 (en) Analgesia-effecting 5-hydroxytryptophan derivatives
ES8601151A1 (es) Procedimiento para la obtencion de derivados de fenilsulfonil-isotiourea sustituidos de efecto herbicida
FI893901A0 (fi) Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi
RU94045867A (ru) Производные пергидроизоиндола и способы их получения
GR871231B (en) Preparation method of novel dihydro -1,4 pyridine derivatives
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
NO20000066L (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse
WO1996006103A3 (de) α-D-PENTOFURANOSID-DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG
HUP0104045A2 (hu) Eljárás 4-[(2&#39;,5&#39;-diamino-6&#39;-halogén-pirimidin-4&#39;-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
DE3464237D1 (en) Tetra-alkyl-2,2,5,5-cyclohexanon-4-ol-1 and its sulfonated derivatives, process and intermediates for its preparation and its use in the synthesis of cis-cyclopropanlactones
MY107215A (en) 3-piperidinylmethylcarboxylate substituted indoles
MY103831A (en) Lactam derivatives.